Beamtree Holdings Ltd (ASX: BMT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Beamtree Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $81.13 million
P/E Ratio 384.62
Dividend Yield 0.00%
Shares Outstanding 289.76 million
Earnings per share -0.018
Dividend per share N/A
Year To Date Return 19.15%
Earnings Yield 0.26%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Beamtree Holdings Ltd (ASX: BMT)
    Latest News

    Two kids in superhero capes.
    Ask a Fund Manager

    2 small-cap ASX shares to handsomely reward patient investors

    Ask A Fund Manager: SG Hiscock's Rory Hunter reveals the 2 little-known stocks that will put smiles on investor faces…

    Read more »

    a man sits on a rocket propelled office chair and flies high above a city
    Technology Shares

    Beamtree (ASX: BMT) share price rockets 21% on acquisition news

    It's a big day on the ASX for Beamtree. Here's what's sent its shares skyrocketing.

    Read more »

    Frequently Asked Questions

    No, Beamtree does not pay dividends at this time.

    Beamtree Holdings Ltd listed on the ASX on 6 June 2019.

    BMT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Beamtree Holdings Ltd

    Beamtree Holdings Ltd (ASX: BMT) is a technology company involved in health data analytics. Its software incorporates artificial intelligence and machine learning to provide an integrated platform for information and knowledge management for health providers.

    Beamtree's platform offers end-to-end support from data collection and classification through quality and performance benchmarking to clinical decision support at point of care. 

    The company says its products help healthcare providers to meet critical challenges in four key areas: rising demand, financial decision-making, quality of clinical outcomes, and patient experience.

    BMT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Dec 2024 $0.28 $0.00 0.00% 39,771 $0.28 $0.28 $0.28
    12 Dec 2024 $0.28 $-0.02 -6.78% 1,856,014 $0.30 $0.30 $0.27
    11 Dec 2024 $0.30 $0.02 7.27% 568,311 $0.27 $0.30 $0.27
    10 Dec 2024 $0.28 $0.02 7.84% 270,982 $0.27 $0.28 $0.26
    09 Dec 2024 $0.26 $0.00 0.00% 20,694 $0.27 $0.27 $0.26
    06 Dec 2024 $0.26 $-0.01 -3.85% 15,000 $0.26 $0.26 $0.26
    05 Dec 2024 $0.26 $-0.01 -3.77% 42,001 $0.27 $0.27 $0.26
    04 Dec 2024 $0.27 $0.01 3.85% 231,463 $0.26 $0.27 $0.26
    03 Dec 2024 $0.26 $-0.01 -3.70% 39,742 $0.26 $0.27 $0.25
    02 Dec 2024 $0.27 $0.01 3.85% 34,898 $0.25 $0.27 $0.25
    29 Nov 2024 $0.26 $-0.02 -7.27% 112,338 $0.28 $0.28 $0.26
    28 Nov 2024 $0.28 $0.03 12.24% 534,951 $0.25 $0.28 $0.25
    27 Nov 2024 $0.25 $-0.01 -3.92% 7,610 $0.24 $0.26 $0.24
    26 Nov 2024 $0.26 $0.01 4.00% 25,868 $0.25 $0.26 $0.25
    25 Nov 2024 $0.25 $0.01 4.08% 352,652 $0.26 $0.26 $0.25
    22 Nov 2024 $0.25 $-0.01 -3.92% 51,947 $0.25 $0.26 $0.25
    21 Nov 2024 $0.26 $0.01 4.08% 157,583 $0.24 $0.26 $0.24
    20 Nov 2024 $0.25 $0.00 0.00% 997,905 $0.23 $0.25 $0.23
    19 Nov 2024 $0.25 $0.01 4.17% 612,436 $0.24 $0.25 $0.24
    18 Nov 2024 $0.24 $0.00 0.00% 286,743 $0.24 $0.24 $0.24
    14 Nov 2024 $0.24 $0.00 0.00% 69,564 $0.25 $0.25 $0.24

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 Jim Birch Issued 4,081 $857
    Director remuneration.
    30 Aug 2024 Jim Birch Issued 71,429 $15,000
    Director remuneration.
    30 Aug 2024 Michael (Mike) Hill Issued 75,510 $15,857
    Director remuneration.
    30 Aug 2024 Brad Lancken Issued 75,510 $15,857
    Director remuneration.
    30 Aug 2024 Emma Gray Issued 75,510 $15,857
    Director remuneration.
    08 May 2024 Emma Gray Buy 60 $12
    On-market trade.
    07 May 2024 Emma Gray Buy 180,822 $37,068
    On-market trade.
    06 May 2024 Emma Gray Buy 669,178 $127,143
    On-market trade.
    02 May 2024 Emma Gray Buy 19,750,000 $4,147,500
    Off-market trade.
    09 Apr 2024 Emma Gray Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Michael (Mike) Hill Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Brad Lancken Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Jim Birch Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    27 Mar 2024 Michael (Mike) Hill Buy 142,000 $29,820
    On-market trade.
    22 Dec 2023 Jim Birch Issued 120,000 $30,000
    Issue of securities.
    22 Dec 2023 Brad Lancken Issued 200,000 $50,000
    Issue of securities.
    22 Dec 2023 Brad Lancken Exercise 1,000,000 $230,000
    Conversion of securities.
    22 Dec 2023 Brad Lancken Issued 1,000,000 $230,000
    Conversion of securities.
    22 Dec 2023 Emma Gray Issued 200,000 $50,000
    Issue of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Jim Birch Non-Executive Director Mar 2021
    Mr Birch has more than 30 years of experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian Digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting firm EY. Jim is currently Chair of the Little Company of Mary Health Care (Calvary), and the Australian Red Cross Blood Service (now known as Lifeblood). Other current directorships include Women's and Children's Hospital Foundation. He is Chair Risk Committee.
    Mr Michael (Mike) Hastings Hill Non-Executive ChairmanNon-Executive Director Jun 2018
    Formerly a Partner of Ernst & Young, has been involved in working with management teams and boards across a number of companies and industries for more than 20 years. He is the MD & CIO, Founder of the Bombora Special Investment Growth Fund. Prior to Bombora he was an Investment Partner with Ironbridge, a private equity investment fund which invested $1.5bn. Michael has served as Chairman of multiple ASX-listed companies over the past nine years. Other current directorships include Design Milk Co Limited (Non-Executive Chairman); Janison Education Group Limited (Non-Executive Chairman); Mad Paws Holdings Limited (Non-Executive Director); Gratifii Limited (Non-Executive Director). He is member of risk Committee.
    Mr Brad Lancken Non-Executive Director Oct 2019
    Mr Lancken is an experienced private and public company executive with over 20 years of experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Bradley has global experience in the technology and SaaS sector including currently acting as a director of Seisma and SimplyAi (technology consulting businesses), Baby Village (ecommerce business) and former roles on the advisory board of China Media Capital Partners and iseekplant.com.au. He also has domestic health care experience, and is a director of Adora Fertility, Genea Fertility, and manages investment in Healthengine (a healthcare and GP marketplace technology company). Bradley serves the community as a Director of the NSW Institute of Sport.
    Ms Emma Gray Non-Executive Director Nov 2022
    Ms Gray is an experienced global business executive with over 20 years of experience in operations, strategy and digital transformation specifically in the retail, consumer and banking sectors. Emma was with ANZ Banking Group for 5 years, most recently as Group Executive, Data and Automation having previously been its Chief Data Officer. Prior to joining ANZ, Emma was a Group Executive with Woolworths, where she focused on Loyalty, Data and Strategy. Prior to executive life, Emma was a partner with Bain & Company, where she specialised in the retail and consumer segments, working across Australia, the United States and the United Kingdom for 15 years. Other current directorships: Sydney Dance Company; Bank of New Zealand. She is Member of Risk Committee.
    Professor Mark Britnell Non-Executive Director May 2024
    Mr Britnell has dedicated all his 35 years of professional experience to the development of healthcare around the world, having worked in 81 countries on 425 plus occasions. He joined KPMG in 2009 as Global Head of Health and later became Global Head of Health, Government & Infrastructure, responsible for nearly one-quarter of KPMG global revenues. He was made Vice Chair of KPMG UK in 2020 and has written two books which have sold in 106 countries and been translated into Mandarin, Korean and Portuguese. He is a professor at the Global Business School for Health at University College London and at the Rotman School of Management, University of Toronto, where he teaches the next generation of healthcare leaders on the comparative performance of health systems globally. He is a Trustee and sits on the Board of the King's Fund and has held several charity positions, including Prostate Cancer UK. He is also the Director of MD Britnell Ltd.
    Mr Timothy Kelsey Chief Executive Officer Oct 2020
    -
    Ms Maria Clemente Company Secretary May 2024
    -
    Timothy Kelsey Chief Executive Officer
    -
    Mark McLellan Chief Financial Officer and Chief Operations Officer
    -
    Marek Stepniak Chief Growth Officer
    -
    Cheryl McCullagh Chief Product Officer
    -
    Maria Clemente Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Invia Custodian Pty Limited 29,183,394 10.10%
    National Nominees Limited 22,075,956 7.64%
    Mirrabooka Investments Limited 18,837,828 6.52%
    Sandtree Pty Ltd 18,035,378 6.24%
    Freestate Holdings Pty Ltd 17,896,624 6.19%
    Amcil Limited 10,045,097 3.48%
    HSBC Custody Nominees (Australia) Limited 9,757,587 3.38%
    Shorebrook Pty Limited 9,556,997 3.31%
    3rd Wave Investors Pty Ltd 7,000,000 2.42%
    Netwealth Investments Limited 6,714,086 2.32%
    Ozren Tosic 3,273,150 1.13%
    Castlereagh Equity Pty Ltd 3,250,000 1.12%
    KM Fitzpatrick & Associates Pty Ltd 3,230,000 1.12%
    Dr Russell Kay Hancock 2,500,000 0.87%
    Mr Christopher Bell 2,499,000 0.86%
    Mrs Clare Mapledoram 2,250,000 0.78%
    David Bambach 2,073,545 0.72%
    Mary Ethna Black 1,728,144 0.60%
    Brazil Farming Pty Ltd 1,700,000 0.59%
    Smc Capital Pty Ltd 1,550,000 0.54%

    Profile

    since

    Note